MFDS Fast‑Track 2026: Navigating GIFT Korea, Priority Review & Conditional Approval
Introduction The MFDS (Ministry of Food and Drug Safety) has embarked on a sweeping overhaul of Korea’s drug review process. Dedicated product‑specific review teams, rolling submissions and parallel GMP inspections have trimmed the standard approval timeline from about 420 days…